Skip to main content
ROVI Subsidiaries
Spain
Germany
France
Italy
Poland
Portugal
United Kingdom
Language
Spanish
Spanish
English
English
English
Español
Home
ROVI
History
Group structure
Business units
International expansion
Strategy
Licenses
Contact
Products
Prescription Pharmaceuticals
Hospital Products
Manufacturing
CDMO
Own product Manufacturing
R&D
Shareholders and Investors
The share
Investor's Calendar
News
Financial and Business Information
CMNV Communications
ESG
Corporate Governance
Telematic assistance access
Prior Registration On-Line Attendance
On-Line Attendance
Sustainability
Responsible governance
Commitment to people
Environmental Commitment
Ethics Channel
Media
FAQS
News
ROVI up to date
Contact
Work with Us
TELEMATIC ASSISTANCE ACCESS
Home
>
Shareholders and investors
> News
News
Find out more about ...
The Share
Investor's Calendar
News
Financial and Business Information
Public Statements Sent to CNMV
ESG
Corporate Governance
News searcher
Year
Year
-Year
2024
2023
2022
2021
2020
2019
2018
Sort by
Fecha publicación
Order
Asc
Desc
2011 First Half Results
0 min
28 Jul, 2011
2011 First Half Results Presentation
0 min
28 Jul, 2011
2011 First Quarter Results
0 min
11 May, 2011
2011 First Quarter Results Presentation
0 min
11 May, 2011
2010 full year results
0 min
24 Feb, 2011
ROVI signs a contract with Farmalíder for the manufacturing of oral forms
0 min
28 Jan, 2011
Marketing of Absorcol and Vytorin, the first from the five licenses from MSD
0 min
18 Jan, 2011
Results of the Phase I trial of oral Bemiparin based on the OCAP technology
0 min
14 Jan, 2011